Schizo Affective Disorder: Clinical Trials

3 trials for Schizo Affective Disorder, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting. 3 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 33Completed 2, Recruiting 1
Phase 21Recruiting 1

Follow Schizo Affective Disorder: new trials by email Literature Review of Schizo Affective Disorder trials Research Report on Schizo Affective Disorder

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy
Sigma-Stim, RUL LAP-ST (Low-Amplitude Pulse Seizure Therapy - Right Unilateral) - Suicidal Ideation, Major Depressive Disorder
Phase 2 / Phase 3RecruitingMichigan State University302024-07-032026-08-12
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia
Sublingual film containing dexmedetomidine (BXCL501), Placebo Film - Agitation, Schizophrenia
Phase 3CompletedBioXcel Therapeutics Inc3802020-01-242026-08-11
Reducing the Burden of Chronic Psychotic Disorders in Tanzania (CAPACITY)
Customized Adherence Enhancement, Haloperidol Decanoate - Schizophrenia, Medication Nonadherence
Phase 3CompletedCase Western Reserve University222019-11-052021-10-12

Narrower conditions

Psychotic Disorders (3)  ·  Schizophrenia (2)  ·  Bipolar Disorder (1)  ·  Depression (1)  ·  Depressive Disorder, Major (1)  ·  Medication Adherence (1)  ·  Psychomotor Agitation (1)  ·  Suicidal Ideation (1)  ·  Suicide (1)

Broader conditions

Behavior (3)  ·  Mental Disorders (3)  ·  Schizophrenia Spectrum and Other Psychotic Disorders (3)  ·  Behavioral Symptoms (2)  ·  Aberrant Motor Behavior in Dementia (1)  ·  Bipolar and Related Disorders (1)  ·  Depressive Disorder (1)  ·  Dyskinesias (1)  ·  Health Behavior (1)  ·  Mood Disorders (1)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Patient Acceptance of Health Care (1)

Interventions

Dexmedetomidine (1)  ·  Haloperidol (1)  ·  haloperidol decanoate (1)

Sponsors

BioXcel Therapeutics Inc (1)  ·  Case Western Reserve University (1)  ·  Michigan State University (1)

Countries

United States (2)  ·  Tanzania (1)

Top investigators

BioXcel MM, MD (1)  ·  Martha Sajatovic, MD (1)  ·  Nagy A Youssef, MD, PhD (1)

Results publications

PMID 35086504, PMID 36002761, PMID 36198061

NIH funding

R21MH114700 (1)